9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine
Modify Date: 2024-02-02 13:10:17
9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine structure
|
Common Name | 9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine | ||
|---|---|---|---|---|
| CAS Number | 132370-61-7 | Molecular Weight | 536.92 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 697.5±65.0 °C at 760 mmHg | |
| Molecular Formula | C26H21ClN4O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 375.6±34.3 °C | |
Use of 9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine |
|---|---|
| Synonym | More Synonyms |
| Description | 9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 697.5±65.0 °C at 760 mmHg |
| Molecular Formula | C26H21ClN4O7 |
| Molecular Weight | 536.92 |
| Flash Point | 375.6±34.3 °C |
| Exact Mass | 536.109863 |
| LogP | 5.32 |
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
| Index of Refraction | 1.677 |
| 9H-Purine, 9-(2-O-acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro- |
| 9-(2-O-Acetyl-3,5-di-O-benzoyl-β-D-xylofuranosyl)-6-chloro-9H-purine |